The European Medicines Agency’s safety committee (PRAC) has published its December 2025 highlights, outlining new risk‑management actions and guidance for medicines widely used across European hospitals, with implications for pharmacy, therapeutics committees and clinical governance teams.

KPJ Healthcare has entered a strategic partnership with Qualitas Health to link its hospital radiology services with Qualitas’ primary care network, expanding access to diagnostics across Malaysia.

Avisena Healthcare will launch a new specialist clinic in Cyberjaya, Malaysia, as the first phase of a broader plan to develop a full-fledged specialist hospital by 2028, strengthening private healthcare infrastructure and specialist services in the Klang Valley corridor.

Indonesia has completed a nationwide hospital and health sector simulation to test and strengthen emergency preparedness for a potential megathrust earthquake in West Sumatra and other high‑risk areas.

Leading hospitals across Europe are rapidly expanding telemedicine and digital patient monitoring in cardiology and critical care units as part of new management and investment programmes launched today.

Truvian Health (“Truvian”) today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance (K251058) for TruVerus™, the industry’s first multimodal blood testing benchtop instrument

CMS has finalized a 2.6% increase in outpatient payment rates for hospitals, effective in 2026, amid ongoing financial pressures and industry concerns.

Asian Hospital and Medical Center and Takeda Healthcare Philippines have signed a major collaboration to deliver broader patient access to advanced medicines for rare and complex conditions, marking a significant step toward sustainable and equitable care delivery for Filipino patients.

The European Commission's proposed 'AI Act Pause' and a €650 million venture fund are sparking major opportunities and competitive shifts in Europe’s MedTech and hospital sectors.

CMS has finalized substantial 2026 Medicare reimbursement increases for Nyxoah’s Genio hypoglossal nerve stimulation implants, strengthening hospital and ASC economics for sleep apnea care.